Willingness to pay and quality of life in patients with atopic dermatitis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Dermatology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00403-013-1402-1.pdf
Reference34 articles.
1. Aberg N, Engstrom I, Lindberg U (1989) Allergic diseases in Swedish school children. Acta Paediatr Scand 78:246–252
2. Akdis CA, Akdis M, Bieber T et al (2006) Diagnosis and treatment of atopic dermatitis in children and adults: european Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol 118:152–169
3. Augustin M, Herberger K, Hintzen S et al (2011) Prevalence of skin lesions and need for treatment in a cohort of 90 880 workers. Br J Dermatol 165:865–873
4. Augustin M, Zschocke I, Lange S et al (1999) Quality of life in skin diseases: methodological and practical comparison of different quality of life questionnaires in psoriasis and atopic dermatitis. Hautarzt 50:715–722 German
5. Bala MV, Wood LL, Zarkin GA et al (1998) Valuing outcomes in health care: a comparison of willingness to pay and quality-adjusted life-years. J Clin Epidemiol 51:667–676
Cited by 92 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm;Journal of the European Academy of Dermatology and Venereology;2023-09-25
2. Psychological Burden and Willingness to Pay Among Korean Rosacea Patients and Their Association With Rosacea Phenotype and Severity: A Multi-Center Cross-Sectional Study;Journal of Cutaneous Medicine and Surgery;2023-08-17
3. Patient preferences for atopic dermatitis treatments: a discrete choice experiment;Journal of Dermatological Treatment;2023-06-22
4. Development of a Specific Variant of Patient Benefit Index (PBI) Assessing Patient Needs, Goals and Benefits in Rosacea Treatment;Patient Preference and Adherence;2023-06
5. Nemolizumab Improves Patient-Reported Symptoms of Atopic Dermatitis with Pruritus: Post Hoc Analysis of a Japanese Phase III Randomized Controlled Trial;Dermatology and Therapy;2023-03-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3